BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32904472)

  • 21. Prophylactic Phenylephrine Increases the Dose Requirement of Oxytocin to Treat Uterine Atony During Cesarean Delivery: A Double-Blinded, Single-Center, Randomized and Placebo-Controlled Trial.
    Shen YH; Yang F; Jin LD; Qian YJ; Xing L; Huang YL; Lin SF; Xiao F
    Front Pharmacol; 2021; 12():720906. PubMed ID: 34744714
    [No Abstract]   [Full Text] [Related]  

  • 22. Weight-based versus fixed dose oxytocin infusion for preventing uterine atony during cesarean section in laboring patients: A randomized trial.
    Tyagi A; Bodh P; Mohta M; Gupta B
    Int J Gynaecol Obstet; 2024 Mar; 164(3):985-991. PubMed ID: 37715535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic Dose of Oxytocin for Uterine Atony during Caesarean Delivery: A Systematic Review.
    Baliuliene V; Vitartaite M; Rimaitis K
    Int J Environ Res Public Health; 2021 May; 18(9):. PubMed ID: 34068723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective Dose of Prophylactic Oxytocin Infusion During Cesarean Delivery in 90% Population of Nonlaboring Patients With Preeclampsia Receiving Magnesium Sulfate Therapy and Normotensives: An Up-Down Sequential Allocation Dose-Response Study.
    Tyagi A; Mohan A; Singh Y; Luthra A; Garg D; Malhotra RK
    Anesth Analg; 2022 Feb; 134(2):303-311. PubMed ID: 34469334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimum effective dose of oxytocin bolus during the caesarean section for patients at high vs low risk of uterine atony: A non-randomized, dual-arm, dose-finding prospective trial.
    Tyagi A; Deep S; Salhotra R; Malhotra R; Singla A
    Indian J Anaesth; 2023 Aug; 67(8):690-696. PubMed ID: 37693025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic effects of continuous intravenous injection and bolus plus continuous intravenous injection of oxytocin in cesarean section.
    Kim TS; Bae JS; Park JM; Kang SK
    Korean J Anesthesiol; 2011 Dec; 61(6):482-7. PubMed ID: 22220225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
    Gallos I; Williams H; Price M; Pickering K; Merriel A; Tobias A; Lissauer D; Gee H; Tunçalp Ö; Gyte G; Moorthy V; Roberts T; Deeks J; Hofmeyr J; Gülmezoglu M; Coomarasamy A
    Health Technol Assess; 2019 Feb; 23(9):1-356. PubMed ID: 30821683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section.
    Boucher M; Horbay GL; Griffin P; Deschamps Y; Desjardins C; Schulz M; Wassenaar W
    J Perinatol; 1998; 18(3):202-7. PubMed ID: 9659650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The optimal oxytocin infusion rate for preventing uterine atony during cesarean delivery in elderly parturients with prior history of cesarean delivery.
    Wang LY; Wang J; Dong JH; Ping ZP; Chen XZ; Wei CN
    Front Pharmacol; 2023; 14():1211693. PubMed ID: 37576820
    [No Abstract]   [Full Text] [Related]  

  • 30. Five unit bolus oxytocin at cesarean delivery in women at risk of atony: a randomized, double-blind, controlled trial.
    King KJ; Douglas MJ; Unger W; Wong A; King RA
    Anesth Analg; 2010 Dec; 111(6):1460-6. PubMed ID: 20889945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist.
    Dyer RA; Butwick AJ; Carvalho B
    Curr Opin Anaesthesiol; 2011 Jun; 24(3):255-61. PubMed ID: 21415725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbetocin for preventing postpartum haemorrhage.
    Su LL; Chong YS; Samuel M
    Cochrane Database Syst Rev; 2012 Feb; (2):CD005457. PubMed ID: 22336812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbetocin for preventing postpartum haemorrhage.
    Su LL; Chong YS; Samuel M
    Cochrane Database Syst Rev; 2012 Apr; (4):CD005457. PubMed ID: 22513931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of methylergometrine and oxytocin on blood loss and uterine contraction during cesarean section].
    Kikutani T; Kikutani M; Oshima M; Sugimoto K; Shimada Y
    Masui; 2006 May; 55(5):590-4. PubMed ID: 16715913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two oxytocin administration protocols in elective cesarean section: 5 iu versus 10 iu.
    Derbel M; Mekki D; Riahi A; Dimassi K; Mebazaa MS; Gara MF
    Tunis Med; 2016 Apr; 94(4):253-258. PubMed ID: 27704507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Median Effective Dose of Oxytocin Needed to Prevent Uterine Atony During Cesarean Delivery in Elderly Parturients.
    Wei CN; Deng JL; Dong JH; Ping ZP; Chen XZ
    Drug Des Devel Ther; 2020; 14():5451-5458. PubMed ID: 33335388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A survey of anaesthetists on uterotonic usage practices for elective caesarean section in Australia and New Zealand.
    Terblanche NC; Otahal P; Sharman JE
    Anaesth Intensive Care; 2021 Nov; 49(6):440-447. PubMed ID: 34657486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial.
    Munn MB; Owen J; Vincent R; Wakefield M; Chestnut DH; Hauth JC
    Obstet Gynecol; 2001 Sep; 98(3):386-90. PubMed ID: 11530117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 5 IU oxytocin bolus and 20 IU oxytocin infusion compared to 5 IU oxytocin bolus and normal saline infusion in the control of blood loss during and after ante-partum lower segment caesarean section: a randomized controlled trial.
    Kajendran J; Silva GR; Ranaraja SK
    Ceylon Med J; 2017 Sep; 62(3):121-127. PubMed ID: 29072051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxytocin-ergometrine co-administration does not reduce blood loss at caesarean delivery for labour arrest.
    Balki M; Dhumne S; Kasodekar S; Kingdom J; Windrim R; Carvalho JC
    BJOG; 2008 Apr; 115(5):579-84. PubMed ID: 18333937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.